Follow Us:

TNF-Alpha Inhibitors

TNF-alpha inhibitors are a class of biological response modifiers that block the activity of tumour necrosis factor-alpha (TNF-α), a cytokine involved in inflammation and immune-system regulation. Excessive TNF-α activity contributes to chronic inflammation and tissue damage in several autoimmune and inflammatory disorders. These medicines work by binding to TNF-α or interfering with its interaction with cellular receptors, thereby reducing inflammatory responses. Common examples include adalimumab, infliximab, etanercept, golimumab and certolizumab pegol. TNF-alpha inhibitors are primarily used to manage inflammatory conditions such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and inflammatory bowel disease.